Derek Chaves Appointed Chief Financial Officer of Corza Medical
July 11, 2024 07:55 ET
|
Corza Medical Inc.
Corza Medical announces the appointment of Derek Chaves as its new Chief Financial Officer (CFO), effective July 8, 2024.
Corza Medical Completes Acquisition of TachoSil Manufacturing Operations
July 01, 2024 07:57 ET
|
Corza Medical Inc.
Corza Medical successfully closed its previously announced acquisition of the TachoSil manufacturing operations in Linz, Austria.
Corza Medical Named “Best Overall MedTech Company” in 8th Annual MedTech Breakthrough Awards Program
May 09, 2024 10:30 ET
|
Corza Medical Inc.
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies WESTWOOD, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Corza Medical...
Corza Medical Opens State-of-the-Art Ophthalmology Center of Technology and Innovation, Demonstrating Commitment to Global Eye Care Community
November 30, 2023 08:05 ET
|
Corza Medical Inc.
Corza Medical opens a new Ophthalmology Center of Technology and Innovation in MO to develop next-gen devices for eye treatments and enhance R&D.
Corza Medical & Envision announce strategic partnership
September 28, 2023 08:05 ET
|
Corza Medical Inc.
Corza Medical and Envision announce today that they have entered into a strategic partnership to propel ophthalmic health forward
Corza Medical Signs Definitive Agreement to Acquire Takeda's TachoSil Manufacturing Operations
April 26, 2023 09:03 ET
|
Corza Medical Inc.
WESTWOOD, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Corza Medical announced today that it has entered into a definitive agreement with a subsidiary of Takeda Pharmaceuticals Company...
Corza Medical Announces Direct Distribution of TachoSil® to the US Market
April 20, 2023 09:05 ET
|
Corza Medical Inc.
WESTWOOD, Mass., April 20, 2023 (GLOBE NEWSWIRE) -- Corza Medical (“Corza”) announced strategic plans to directly sell TachoSil®, a best-in-class surgical fibrin sealant patch trusted by medical...